Medication info
Lisand Plus Tablet

Lisand Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Geonil Biopharm Co., Ltd.
Appearance
Pale orange oval film-coated tablets
Packaging
4 tablets/PPTP [4 tablets (4 tablets/PTP x 1)]
Approval status
Active

MFDS item code 202001703 · Approved 2020.03.11 · Insurance code 073000230

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Take 1 tablet of this medicine orally once weekly. Older adults: No dose adjustment is needed in older adults (60 years or older), because the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is needed in patients with a creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this medicine. For adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day, at least 2 hours before or after eating or drinking. Take this medicine with a sufficient amount of plain water (170 ~ 230ml) while sitting or standing upright to help it reach the stomach easily and reduce the possibility of esophageal irritation. Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Do not lie down for at least 30 minutes after taking this medicine. Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to800 IU. This medicine, taken once weekly, provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
The safety and efficacy of this medicine in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Geonil Biopharm Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Adults: Take 1 tablet of this medicine orally once weekly. Older adults: No dose adjustment is needed in older adults (60 years or older), because the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. Patients with renal impairment: No dose adjustment is needed in patients with a creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance below 30 mL/min. Food interferes with the absorption of this medicine. For adequate absorption, take it as follows. Take it at least 30 minutes before breakfast, or at any time of day, at least 2 hours before or after eating or drinking. Take this medicine with a sufficient amount of plain water (170 ~ 230ml) while sitting or standing upright to help it reach the stomach easily and reduce the possibility of esophageal irritation. Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Do not lie down for at least 30 minutes after taking this medicine. Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may need additional vitamin D supplements. Patients with gastrointestinal malabsorption syndromes may need higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400 IU to800 IU. This medicine, taken once weekly, provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

The safety and efficacy of this medicine in children and adolescents who are still growing have not been established.

Precautions

This medication may irritate the gastrointestinal mucosa, causing esophageal issues such as esophagitis and esophageal ulcers. If symptoms such as difficulty swallowing, pain behind the sternum, or heartburn occur after taking, discontinue use immediately and consult a physician. Take this medication with a sufficient amount of water and do not lie down for at least 30 minutes after taking. This medication should not be administered to patients with certain esophageal diseases or severely impaired kidney function, or patients with lactose intolerance. Caution should be exercised when taking this medication with drugs or foods that contain divalent cations such as calcium, magnesium, and iron, as it may interfere with drug absorption. Additionally, during the course of taking this medication, supplementation with calcium and vitamin D is recommended, and it is important to maintain sufficient exercise and a healthy lifestyle. Rarely, serious side effects such as jaw osteonecrosis, severe skin reactions, or liver function abnormalities may occur; if any unusual symptoms arise, notify a physician immediately. Women who are pregnant or breastfeeding should consult a physician before taking this medication, and it should be kept out of the reach of children for safety.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • asymptomatic hypocalcemia
Show 113 more
  • asymptomatic hypophosphatemia
  • infection
  • lumbago
  • pain
  • abdominal pain
  • throat pain
  • weakness
  • chest pain
  • neoplasm
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disorders
  • rectal diseases
  • dental diseases
  • petechiae
  • anemia
  • arthralgia
  • joint disorders
  • myalgia
  • bone pain
  • bone disorders
  • leg cramps
  • bursitis
  • tendon disorders
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • trauma-related injury
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • dry mouth
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falls
  • dizziness
  • bronchitis
  • influenza
  • nasopharyngitis
  • upper respiratory tract infection
  • osteoarthritis
  • limb pain
  • muscle rigidity
  • neck pain
  • muscular weakness
  • hypercholesterolemia
  • uveitis
  • iritis
  • jawbone necrosis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • skin reaction
  • jaundice
  • external ear bone necrosis
  • anorexia
  • chest discomfort
  • palpitations
  • increased sweating
  • flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • facial edema
  • hair loss
  • abnormal olfaction
  • hypocalcemia
  • hypercalcemia
  • hypercalciuria
  • polyuria
  • weakness
  • somnolence

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air or moisture, and it should be kept at a temperature between 1 and 30 degrees Celsius. Therefore, it is advisable to keep the medication in a cool, dry place until use.

Appearance and packaging

Appearance

Pale orange oval film-coated tablets

Package unit

4 tablets/PPTP [4 tablets (4 tablets/PTP x 1)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.